Painful Diabetic Peripheral Neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Diagnosed with type 1 or type 2 diabetes mellitus; (2) The patient was diagnosed with painful diabetic peripheral neuropathy; (3) Aged 18-75 years; (4) The numeric rating scale for pain intensity of diabetic peripheral neuropathy =4 points; (5) Have not received drug treatment for painful diabetic peripheral neuropathy in the past 1 month; (6) Have not received acupuncture treatment in the past 3 months and have not participated in other ongoing clinical studies; (7) Sign informed consent to participate in the study voluntarily.
Exclusion criteria
Exclusion criteria: (1) Glycosylated hemoglobin > 9%; (2) Implantation of a pacemaker; (3) Pregnancy lactation or planned pregnancy; (4) Patients with malignant tumors or chemotherapy severe cardiovascular and cerebrovascular diseases infectious diseases vitamin B12 deficiency cervical and lumbar spine diseases hereditary neuropathy liver and kidney insufficiency; Alcoholism; (5) Have a history of cerebral hemorrhage inherited hemorrhagic disease (such as hemophilia) or are using anticoagulant drugs such as warfarin; (6) Foot ulcer or gangrene; (7) Patients with cognitive dysfunction aphasia or mental disorders cannot cooperate with this study; (8) Patients with peripheral neuropathy pain caused by other reasons; (9) Others are not appropriate for this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Response rate for Numeric rating scale;Total symptom score;Beck Anxiety Inventory score;Pittsburgh Sleep Quality Index (PSQI) score;Blinding assessment;Beck Depression Inventory-II score;Nerve conduction velocity;Treatment expectancy;12-item short-form health survey; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine